One-Carbon Metabolism in Liver Health and Disease

[1]  S. Baker,et al.  Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease. , 2015, Current drug targets.

[2]  T. Shlomi,et al.  Quantitative flux analysis reveals folate-dependent NADPH production , 2014, Nature.

[3]  S. Murphy,et al.  Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease , 2014, Hepatology.

[4]  Shelly C. Lu,et al.  Excess S‐adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis , 2013, Hepatology.

[5]  Shelly C. Lu,et al.  S-adenosylmethionine in liver health, injury, and cancer. , 2012, Physiological reviews.

[6]  D. Calvisi,et al.  Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression , 2012, Hepatology.

[7]  S. Zeisel,et al.  Deletion of Betaine-Homocysteine S-Methyltransferase in Mice Perturbs Choline and 1-Carbon Metabolism, Resulting in Fatty Liver and Hepatocellular Carcinomas* , 2011, The Journal of Biological Chemistry.

[8]  E. Cadenas,et al.  Regulation of Mitochondrial Glutathione Redox Status and Protein Glutathionylation by Respiratory Substrates* , 2010, The Journal of Biological Chemistry.

[9]  Shelly C. Lu,et al.  Fatty liver and fibrosis in glycine N‐methyltransferase knockout mice is prevented by nicotinamide , 2010, Hepatology.

[10]  Eva Albers,et al.  Metabolic characteristics and importance of the universal methionine salvage pathway recycling methionine from 5′‐methylthioadenosine , 2009, IUBMB life.

[11]  S. Clarke,et al.  Multiple Motif Scanning to Identify Methyltransferases from the Yeast Proteome* , 2009, Molecular & Cellular Proteomics.

[12]  Shelly C. Lu.  Regulation of glutathione synthesis. , 2009, Molecular aspects of medicine.

[13]  Shelly C. Lu,et al.  Loss of the glycine N‐methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice , 2007, Hepatology.

[14]  C. McClain,et al.  Glutathione‐enhancing agents protect against steatohepatitis in a dietary model , 2006, Journal of biochemical and molecular toxicology.

[15]  R. Garrett,et al.  The Genome of Sulfolobus acidocaldarius, a Model Organism of the Crenarchaeota , 2005, Journal of bacteriology.

[16]  D. Russell,et al.  Clinical importance of the cytochromes P450 , 2002, The Lancet.

[17]  Shelly C. Lu,et al.  Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  Shelly C. Lu,et al.  S‐adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells , 2002, Hepatology.

[19]  Shelly C. Lu,et al.  Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Shelly C. Lu,et al.  Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. , 2000, Journal of hepatology.

[21]  R. Porter,et al.  Mammalian mitochondrial inner membrane cationic and neutral amino acid carriers. , 2000, Biochimica et biophysica acta.

[22]  J. Rodés,et al.  S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. , 1999, Journal of hepatology.

[23]  W. Haefeli,et al.  Influence of oral S-adenosylmethionine on plasma 5-methyltetrahydrofolate, S-adenosylhomocysteine, homocysteine and methionine in healthy humans. , 1997, The Journal of pharmacology and experimental therapeutics.

[24]  J. Hwang,et al.  Changes in S‐adenosylmethionine synthetase in human liver cancer: Molecular characterization and significance , 1996, Hepatology.

[25]  M. Pajares,et al.  S‐adenosylmethionine treatment prevents carbon tetrachloride—induced S‐adenosylmethionine synthetase inactivation and attenuates liver injury , 1992, Hepatology.

[26]  Cho-il Kim,et al.  S‐Adenosyl‐L‐methionine attenuates alcohol‐induced liver injury in the baboon , 1990, Hepatology.

[27]  G. Vendemiale,et al.  Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. , 1989, Scandinavian journal of gastroenterology.

[28]  K. L. Hoover,et al.  Hepatic DNA methylation and liver tumor formation in male C3H mice fed methionine- and choline-deficient diets. , 1986, Journal of the National Cancer Institute.

[29]  S. Mudd,et al.  Labile methyl balances for normal humans on various dietary regimens. , 1975, Metabolism: clinical and experimental.

[30]  Shelly C. Lu,et al.  Abnormal hepatic methionine and glutathione metabolism in patients with alcoholic hepatitis. , 2004, Alcoholism, clinical and experimental research.